Aprogen Biologics Statistics
Total Valuation
KRX:003060 has a market cap or net worth of KRW 215.83 billion. The enterprise value is 330.95 billion.
Market Cap | 215.83B |
Enterprise Value | 330.95B |
Important Dates
The last earnings date was Tuesday, May 13, 2025.
Earnings Date | May 13, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
KRX:003060 has 310.99 million shares outstanding. The number of shares has increased by 143.47% in one year.
Current Share Class | 310.99M |
Shares Outstanding | 310.99M |
Shares Change (YoY) | +143.47% |
Shares Change (QoQ) | -0.39% |
Owned by Insiders (%) | 0.01% |
Owned by Institutions (%) | 0.16% |
Float | 198.13M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 3.15 |
PB Ratio | 0.65 |
P/TBV Ratio | 0.66 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -2.33 |
EV / Sales | 4.82 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -6.07 |
Financial Position
The company has a current ratio of 0.57, with a Debt / Equity ratio of 0.53.
Current Ratio | 0.57 |
Quick Ratio | 0.34 |
Debt / Equity | 0.53 |
Debt / EBITDA | n/a |
Debt / FCF | -3.23 |
Interest Coverage | -11.27 |
Financial Efficiency
Return on equity (ROE) is -40.78% and return on invested capital (ROIC) is -8.13%.
Return on Equity (ROE) | -40.78% |
Return on Assets (ROA) | -6.96% |
Return on Invested Capital (ROIC) | -8.13% |
Return on Capital Employed (ROCE) | -17.17% |
Revenue Per Employee | 182.02M |
Profits Per Employee | -376.62M |
Employee Count | 377 |
Asset Turnover | 0.11 |
Inventory Turnover | 1.67 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -53.23% in the last 52 weeks. The beta is -0.04, so KRX:003060's price volatility has been lower than the market average.
Beta (5Y) | -0.04 |
52-Week Price Change | -53.23% |
50-Day Moving Average | 694.54 |
200-Day Moving Average | 962.85 |
Relative Strength Index (RSI) | 57.43 |
Average Volume (20 Days) | 388,555 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:003060 had revenue of KRW 68.62 billion and -141.98 billion in losses. Loss per share was -895.54.
Revenue | 68.62B |
Gross Profit | -16.23B |
Operating Income | -68.68B |
Pretax Income | -142.02B |
Net Income | -141.98B |
EBITDA | -48.92B |
EBIT | -68.68B |
Loss Per Share | -895.54 |
Balance Sheet
The company has 61.38 billion in cash and 175.99 billion in debt, giving a net cash position of -114.61 billion or -368.52 per share.
Cash & Cash Equivalents | 61.38B |
Total Debt | 175.99B |
Net Cash | -114.61B |
Net Cash Per Share | -368.52 |
Equity (Book Value) | 334.47B |
Book Value Per Share | 1,692.46 |
Working Capital | -102.57B |
Cash Flow
In the last 12 months, operating cash flow was -37.39 billion and capital expenditures -17.14 billion, giving a free cash flow of -54.53 billion.
Operating Cash Flow | -37.39B |
Capital Expenditures | -17.14B |
Free Cash Flow | -54.53B |
FCF Per Share | -175.33 |
Margins
Gross margin is -23.65%, with operating and profit margins of -100.09% and -206.91%.
Gross Margin | -23.65% |
Operating Margin | -100.09% |
Pretax Margin | -206.97% |
Profit Margin | -206.91% |
EBITDA Margin | -71.30% |
EBIT Margin | -100.09% |
FCF Margin | n/a |
Dividends & Yields
KRX:003060 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -143.47% |
Shareholder Yield | n/a |
Earnings Yield | -65.79% |
FCF Yield | -25.26% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on March 27, 2024. It was a reverse split with a ratio of 0.1.
Last Split Date | Mar 27, 2024 |
Split Type | Reverse |
Split Ratio | 0.1 |
Scores
KRX:003060 has an Altman Z-Score of -0.78. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -0.78 |
Piotroski F-Score | n/a |